Cantitate/Preț
Produs

Acute Leukemias VI: Prognostic Factors and Treatment Strategies: Haematology and Blood Transfusion Hämatologie und Bluttransfusion, cartea 38

Editat de Thomas Büchner, Wolfgang Hiddemann, Bernhard Wörmann, Günter Schellong, Jörg Ritter, Ursula Creutzig
en Limba Engleză Paperback – 6 dec 2011

Din seria Haematology and Blood Transfusion Hämatologie und Bluttransfusion

Preț: 110210 lei

Preț vechi: 116010 lei
-5% Nou

Puncte Express: 1653

Preț estimativ în valută:
21091 22183$ 17569£

Carte tipărită la comandă

Livrare economică 04-18 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783642643798
ISBN-10: 3642643795
Pagini: 1036
Ilustrații: XXXIV, 997 p.
Dimensiuni: 155 x 235 x 54 mm
Greutate: 1.42 kg
Ediția:Softcover reprint of the original 1st ed. 1997
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Haematology and Blood Transfusion Hämatologie und Bluttransfusion

Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Research

Cuprins

Leukemia Cell Biology: Cytogenetics.- Leukemia Cell Biology: Molecular Biology.- Leukemia Cell Biology: Cytokines.- Leukemia Cell Biology.- Residual Leukemia.- New Strategies: Nucleoside Analogs.- New Strategies: Idarubicin.- New Strategies Using Growth Factors: G-CSF.- New Strategies Using Growth Factors: GM-CSF, PIXY 321.- New Strategies: Antifungal Treatment.- Pharmacology.- ALL in Children.- ALL in Adults.- AML in Children.- AML in Adults.- Secondary Leukemia, Myelodysplastic Syndrome.- Supportive Care.

Textul de pe ultima copertă

For 10 years the book series Acute Leukemias has been providing updates on the rapid progress being made internationally concerning this group of diseases. The fifth volume mainly addressed experimental approaches, but the present issue presents both therapeutic and prognostic aspects of the most recent results from major multicenter clinical trials. Additional chapters report new trends in leukemia cell biology,the monitoring of minimal residual disease, and secondary leukemias, as well as new antileukemic drugs, antimicrobial strategies, and the use of cytokines. The combined efforts against acute leukemias described in this book explain the recent improvements in the outcome of patients suffering from acute leukemias.